Brind.

Knight entered into an agreement on August 5, 2025, regarding CREXONT rights with Amneal Pharmaceuticals, Inc.

2 reports, 1 independent Updated Aug 5

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Knight entered into an agreement on August 5, 2025, regarding CREXONT rights with Amneal Pharmaceuticals, Inc.

Who's involved

What this event is mainly about

Knight Amneal Pharmaceuticals, Inc.

Keep exploring

The entities involved

Knight
historic business based in Salisbury
- A company named Knight operates a restaurant from a 15th-century building located in Glastonbury, which is based in Somerset.Wed 16:38
Amneal Pharmaceuticals, Inc.
American publicly traded generics and specialty pharmaceutical company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 5GlobeNewswireKnight Therapeutics Announces Regulatory Submission of CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Mexico MONTREAL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX
Jul 18GlobeNewswireKnight Therapeutics Announces Filing of New Drug Submission for CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Canada MONTREAL, July 18, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics I